TABLE 3.
Numbers of errors and discrepancies between MICs obtained by the commercial techniques and the EUCAST reference procedure, by antifungal agent
| Antifungal agenta | No. of errors or discrepancies between EUCAST andb: |
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitek |
Etest |
SYOne |
|||||||||||||
| VME | ME | MiE | SD | NSD | VME | ME | MiE | SD | NSD | VME | ME | MiE | SD | NSD | |
| AMB | 0 | 2 | 0 | 5 | 0 | 5 | |||||||||
| 5FC | 0 | 3 | 1 | 4 | 0 | 3 | |||||||||
| FLZ | 8 | 0 | 23 | 7 | 0 | 24 | 7 | 0 | 20 | ||||||
| VOR | 0 | 0 | 10 | 0 | 0 | 6 | 0 | 0 | 8 | ||||||
| Total | 8 | 0 | 33 | 0 | 5 | 7 | 0 | 30 | 1 | 9 | 7 | 0 | 28 | 0 | 8 |
a
AMB, amphotericin B; 5FC, flucytosine; FLC, fluconazole; VRC, voriconazole.
b
Vitek, Vitek 2 system technique; EUCAST, EUCAST reference procedure; Etest, Etest method; SYOne, Sensititre YeastOne technique; VME, very major errors; ME, major errors; MiE, minor errors; SD, substantial discrepancies; NSD, nonsubstantial discrepancies.